LB Pharmaceuticals, Inc. (LBRX)

42.99 +0.52 (+1.22%) USD  |  NASDAQ  |  Sep 21, 16:00
42.95 -0.04 (-0.09%) Pre-Market: 20:00
More

LB Pharmaceuticals EPS Diluted (TTM) : -2.981 for June 30, 2026

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for LBRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -2.981
March 31, 2026 -1.486
December 31, 2025 -1.021
September 30, 2025 -0.7933
June 30, 2025 -1.285
March 31, 2025 -2.302
Date Value
December 31, 2024 -2.812
September 30, 2024 -2.735
June 30, 2024 -2.103
March 31, 2024 -0.8687
March 31, 2023 -0.1489

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Ligand Pharmaceuticals, Inc. 9.354
Neumora Therapeutics, Inc. -1.233
ANI Pharmaceuticals, Inc. 4.632
Corcept Therapeutics, Inc. 0.4187
Veru, Inc. -0.6109